> top > docs > PubMed:11133022 > spans > 0-124 > annotations

PubMed:11133022 / 0-124 JSONTXT

Annnotations TAB JSON ListView MergeView

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 0-22 Glycan_Motif denotes Globotriaosyl ceramide https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-124 Sentence denotes Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.
T1 0-124 Sentence denotes Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 0-22 https://glytoucan.org/Structures/Glycans/G00059MO denotes Globotriaosyl ceramide

DisGeNET

Id Subject Object Predicate Lexical cue
T0 80-84 gene:930 denotes CD19
T1 109-117 disease:C0024299 denotes lymphoma
R1 T0 T1 associated_with CD19,lymphoma

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 99-117 Phenotype denotes Burkitt's lymphoma HP:0030080

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 99-117 Disease denotes Burkitt's lymphoma http://purl.obolibrary.org/obo/MONDO_0007243

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 99-117 Phenotype denotes Burkitt's lymphoma HP:0030080

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 99-117 Disease denotes Burkitt's lymphoma http://purl.obolibrary.org/obo/MONDO_0007243

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-124 Sentence denotes Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.
T1 0-124 Sentence denotes Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-124 Sentence denotes Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.